Patent 7317011 was granted and assigned to Pharmacia & Upjohn on January, 2008 by the United States Patent and Trademark Office.
Disclosed herein are methods of treating an individual suffering from peripheral neuropathy. The methods generally include administration of a therapeutic amount of optically pure (S,S) reboxetine, or a pharmaceutically acceptable salt thereof. Embodiments of these methods can diminish adverse side effects.